A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer.

BMC Med Genomics · 2022 · PMC8822680 · PMID 35135561

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

found that highly significant and frequent hypomethylation of cancer-specific promoter of TFF3 in malignant prostate cancer [ 43 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.